Award
National Cancer Institute 5R01CA284315-04
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
Recipient
Methodist Hospital Research Institute
Award Amount
$654,245.00
Ceiling
$654,245.00
Awarded
July 08, 2023
Identifier
5R01CA284315-04
Award for research on targeted therapies for metaplastic breast cancer focusing on PI3K and NOS pathways, funded by NIH/NCI with $654,245 awarded.
Description
The project involves investigating targeted therapies for metaplastic breast cancer, focusing on the PI3K and NOS pathways. The project is funded by the NIH/NCI with a total award amount of $654,245. The project duration is from July 8, 2023, to June 30, 2028. The project is managed by Methodist Hospital Research Institute in Houston, TX.